DPL-68178-27906
3 vaccinations
7 coded responses
21 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 080 / NJ
- Registered
- 2021-01-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Dose 1 — Moderna
-
2021-01-30
Registered in v-safe
-
2021-01-30
Health check-in — day 7, dose 1Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-02-04
Survey response — day 14, dose 1MedDRA: Chills, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth, Malaise — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Injection site became slightly itchy, but tender, more swollen, red, warm to touch and more sore one week after vaccine, this is after initial symptoms were getting better. Also, chills and malaise today.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-11
Survey response — day 21, dose 1MedDRA: Diarrhoea, SARS-CoV-2 test, Upper respiratory tract infection — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Sudden onset diarrhea 5 days; upper respiratory infection · Healthcare visit (other): COVID-19 testMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-11
Report sent to call center — day 21, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-18
Dose 2 — Moderna
-
2021-02-18
Health check-in — day 0, dose 2Feeling: Good · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-02-19
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Loss of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-21
Survey response — days 1–6 daily, dose 2MedDRA: Body temperature increased — Feeling: Fair · Site: Pain, Itching · Joint pains, Muscle or body aches, Nausea · Be unable to do your normal daily activitiesFree text: Day after vaccine (day 2) temp up to 102MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling, Itching · Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-23
Survey response — days 1–6 daily, dose 2MedDRA: Body temperature increased — Feeling: Fair · Site: Pain, Itching · Fever · Headache, Muscle or body aches, Abdominal painFree text: Normal temp is 96.4; slight elevationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-25
Health check-in — day 7, dose 2Feeling: Good · Site: Pain, Itching · Joint pains, Fatigue or tirednessAdult check-in
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-03
- 2021-05-22
- 2021-07-29
- 2021-08-19
-
2021-11-10
Dose 3 — Moderna
- 2022-02-20
-
2022-05-13
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Positive COVID with symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-05-13
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-05-16
-
2022-05-16
Callback requested for07:00PM ET
-
2022-05-16
Call successfulCompleted over the phone
-
2022-05-16
Call successfulCompleted over the phone
-
2022-11-11
Survey response — 12 months, dose 3MedDRA: Adverse reaction — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Slight reaction after new Covid boosterMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Moderna | |
| 2 | 2021-02-18 | Moderna | |
| 3 | 2021-11-10 | Moderna | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 2
1 wait over 3 months for a first call
Free text
Release 3 — day 14, dose 1
Symptoms: Injection site became slightly itchy, but tender, more swollen, red, warm to touch and more sore one week after vaccine, this is after initial symptoms were getting better. Also, chills and malaise today.
Release 4 — day 21, dose 1
Symptoms: Sudden onset diarrhea 5 days; upper respiratory infection
Healthcare visit (other): COVID-19 test
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Loss of appetite
Systemic reaction (other): Day after vaccine (day 2) temp up to 102
Systemic reaction (other): Normal temp is 96.4; slight elevation
Release 11 — 6 months, dose 3
Symptoms: Positive COVID with symptoms
Release 12 — 12 months, dose 3
Symptoms: Slight reaction after new Covid booster
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | SARS-CoV-2 test | ✓ | ✓ | ✓ |
| SD | Adverse reaction | · | · | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Malaise | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
| SRO | Body temperature increased | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release